Last updated: November 28, 2024
Sponsor: Abiomed Inc.
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chest Pain
Congestive Heart Failure
Hyponatremia
Treatment
V-A ECMO AUTO Mode algorithm
Clinical Study ID
NCT05759377
2022-R02
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with ongoing or planned ECpella therapy
Exclusion
Exclusion Criteria:
Age < 18 years
Treatment with other than VA ECMO setup
Treatment with Impella CP® heart pump only
Study Design
Total Participants: 30
Treatment Group(s): 1
Primary Treatment: V-A ECMO AUTO Mode algorithm
Phase:
Study Start date:
October 11, 2023
Estimated Completion Date:
June 01, 2025
Study Description
Connect with a study center
Uniklinik RWTH Aachen
Aachen, NRW 52074
GermanyActive - Recruiting
HDZ NRW
Bad Oeynhausen, NRW 32545
GermanyActive - Recruiting
Herzzentrum Dresden GmbH
Dresden, Saxony 01307
GermanyActive - Recruiting
Universitäres Herz- und Gefäßzentrum Hamburg
Hamburg, 20251
GermanyActive - Recruiting
UKGM Universtitätsklinikum Marburg
Marburg,
GermanySite Not Available
Brüderkrankenhaus Trier
Trier,
GermanySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.